PRTA - Prothena Corporation plc
NEXT EARNINGS:
May 14, 2026
EPS Est: $-0.39
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$26.00
DETAILS
HIGH:
$36.00
LOW:
$19.00
MEDIAN:
$20.00
CONSENSUS:
$26.00
UPSIDE:
189.86%
Market Cap:
482.85M
Volume:
440,386
Avg Volume:
583,250
52 Week Range:
4.32-16.16
Sector:
Healthcare
Industry:
Biotechnology
Beta:
-0.12
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
IE
Employees:
163
IPO Date:
2012-12-18
EPS (TTM):
-4.53
P/E Ratio:
-2.11
Revenue (TTM):
9.68M
Total Assets:
326.80M
Total Debt:
13.86M
Cash & Equiv:
307.53M
Rev Growth (5Y):
62.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-64.5%
Debt/Equity:
0.05
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $-0.44 | $-0.45 | +2.2% | $21000 | $1.3M | -98.4% |
| 2025-11-06 | $-0.67 | $-0.60 | -11.7% | $2.4M | $666670 | +262.2% |
| 2025-08-04 | $-1.86 | $-1.11 | -67.6% | $4.4M | $6.6M | -33.4% |
| 2025-05-08 | $-1.12 | $-0.92 | -21.7% | $2.8M | $15.3M | -81.6% |
| 2025-02-20 | $-1.08 | $-1.02 | -5.9% | $2.1M | $7.5M | -71.8% |
| 2024-11-12 | $-1.10 | $-1.18 | +6.8% | $970000 | $1.2M | -21.1% |
| 2024-08-08 | $1.22 | $-1.05 | +216.2% | $132.0M | $10.7M | +1130.3% |
| 2024-05-08 | $-1.34 | $-1.21 | -10.7% | $50000 | $1.8M | -97.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.68M | 135.16M | 91.37M | 53.91M | 200.58M | 853,000 | 814,000 | 955,000 | 27.52M | 1.05M | 1.61M | 50.85M |
| Net Income | (244.09M) | (122.31M) | (147.03M) | (116.95M) | 66.97M | (111.14M) | (77.68M) | (155.65M) | (153.24M) | (160.11M) | (80.61M) | (7.15M) |
| EPS | -4.53 | -2.27 | -2.76 | -2.47 | 1.51 | -2.78 | -1.95 | -3.93 | -4.07 | -4.66 | -2.66 | -0.29 |
| Total Assets | 326.80M | 547.11M | 696.38M | 758.03M | 609.37M | 332.98M | 419.27M | 498.80M | 496.33M | 459.98M | 385.24M | 304.12M |
| Total Debt | 13.86M | 10.84M | 11.84M | 6.47M | 12.33M | 17.84M | 22.94M | 51.55M | 52.25M | 51.32M | 0 | 0 |
| Cash & Equivalents | 307.53M | 471.39M | 618.83M | 710.41M | 579.09M | 295.38M | 375.72M | 427.66M | 417.62M | 386.92M | 370.59M | 293.58M |
| Operating Cash Flow | N/A | (150.05M) | (133.91M) | (108.82M) | 92.61M | (80.36M) | (52.97M) | (28.28M) | (131.18M) | (117.27M) | (62.45M) | (683,000) |
| Free Cash Flow | N/A | (150.35M) | (136.72M) | (109.28M) | 92.03M | (80.56M) | (53.52M) | (30.04M) | (134.81M) | (133.91M) | (63.84M) | (1.21M) |
| FCF per Share | N/A | -2.80 | -2.57 | -2.31 | 2.08 | -2.02 | -1.34 | -0.76 | -3.58 | -3.90 | -2.11 | -0.05 |
| Book Value | 280.47M | 486.93M | 561.37M | 622.04M | 466.04M | 184.01M | 272.92M | 323.00M | 407.19M | 365.40M | 360.67M | 289.89M |
| Cash & ST Investments | 307.53M | 471.39M | 618.83M | 710.41M | 579.09M | 295.38M | 375.72M | 427.66M | 417.62M | 386.92M | 370.59M | 293.58M |
| ROC Equity | -0.87 | -0.25 | -0.26 | -0.19 | 0.14 | -0.60 | -0.28 | -0.48 | -0.38 | -0.44 | -0.22 | -0.02 |